Glaucoma has long been treated as a plumbing problem of the eye, managed mainly by lowering pressure rather than protecting the tissue that is slowly dying. A new wave of research is now pointing to a ...

India, May 15 -- Calcitonin gene-related peptide (CGRP) inhibitor drugs used for migraine prevention may be linked to a lower risk of glaucoma, according to a report published May 6, 2026, in American ...

To reduce elevated intraocular pressure (IOP) in glaucoma or ocular hypertension where adjunctive or replacement therapy is warranted. Combigan contains two drugs widely used in the treatment of ...

According to financial terms announced Monday night, Geneva, Switzerland-based Alcon will pay $15.25 for each share of Aerie, a 37% premium to the stock’s closing price on Monday. Aerie went public in ...

A drug commonly used to treat glaucoma has been shown in zebrafish and mice to protect against the build-up in the brain of the protein tau, which causes various forms of dementia and is implicated in ...

Expert Rev Ophthalmol. 2010;5(3):405-412. Damage and inflammation of the corneal epithelium can cause an increase of inflammatory cells, detected by confocal microscopy, and inflammatory mediators.

Glaucoma is a progressive eye disorder characterized by fluid buildup inside the eye, causing ocular hypertension. By 2040, it is estimated that 111.8 million people worldwide will be affected by ...

Certain drugs to prevent migraine are associated with a reduced risk of glaucoma. Glaucoma is a leading cause of blindness. Migraine itself is associated with an increased risk of glaucoma. The study ...

Experiments on zebrafish and mice have shown that a drug used to treat glaucoma may protect against tau protein buildup in the brain, a key marker of dementias such as Alzheimer's disease. The ...

How equitably are glaucoma medications being dispensed across a universal health care system, and how have prescribing ...

Shuchi Patel, MD: Good afternoon, Dr. Ruth Williams. Thank you so much for taking the time to have a discussion with us regarding a topic that is of emerging interest. Today we're going to talk about ...